Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 29 (RPS2P29) is a processed pseudogene derived from the functional ribosomal protein S2 (RPS2) gene. Pseudogenes such as RPS2P29 do not code for functional proteins and are generally considered non-coding, although they may retain sequence similarity to their parent gene. Multiple RPS2 pseudogenes, including RPS2P29, exist dispersed throughout the human genome as a result of retrotransposition or genomic duplication events. These pseudogenes are not recognized as therapeutic targets and have no established biological or disease role. RPS2P29 is a non-coding pseudogene without a therapeutic, biological, or disease-linked function. Its presence in genomic databases reflects sequence similarity to ribosomal protein S2 genes, but it is not considered a valid drug target or a biologically relevant molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 29 (RPS2P29).